Cargando…
Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin
BACKGROUND: Colon adenocarcinomas are refractory to a number of widely used anticancer agents. Multifactorial mechanisms have been implicated in this intrinsically resistant phenotype, including deregulation of cell death pathways. In this regard, the p53 protein has a well established role in the c...
Autores principales: | Ravizza, Raffaella, Gariboldi, Marzia B, Passarelli, Laura, Monti, Elena |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544559/ https://www.ncbi.nlm.nih.gov/pubmed/15601469 http://dx.doi.org/10.1186/1471-2407-4-92 |
Ejemplares similares
-
Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin.
por: Dolfini, E., et al.
Publicado: (1997) -
Protective role of p53 in doxorubicin-induced cardiomyopathy as a mitochondrial disease
por: Nishi, Masahiro, et al.
Publicado: (2020) -
Absence of p21 expression is associated with abnormal p53 in human breast carcinomas.
por: Ellis, P. A., et al.
Publicado: (1997) -
The predictive value of p53, p53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma
por: Okumura, H, et al.
Publicado: (2005) -
Overexpression of p53 and long-term survival in colon carcinoma.
por: Auvinen, A., et al.
Publicado: (1994)